Month: March 2022
-
Higher Doses of Anti-Seizure Medications May Be Needed in Pregnancy
Higher doses of anti-seizure medications may be necessary during pregnancy, according to a recent study.
-
New Genetic Risk Factors for Arrhythmia Discovered
A recent study published in Nature Genetics identified 10 new genetic regions associated with Brugada syndrome, a cardiac arrhythmia disorder.
-
Feinberg Ranks Among Top Medical Schools in the Nation
Northwestern University Feinberg School of Medicine has been recognized as one of the best medical schools in the nation, ranking 17th among research-oriented institutions, according to the latest U.S. News & World Report rankings.
-
Investigators Identify Potential Therapeutic Target for Pancreatic Cancer
Investigators discovered that decreased expression of the G alpha 13 protein in mice and human pancreatic tumors promotes tumor growth, according to recent findings.
-
Northwestern Investigates COVID-19: Antibodies, Global Surveillance, Women in Research
Northwestern Medicine continues to help advance the understanding of the COVID-19 pandemic and its widespread impact, from investigating antibody protection against COVID-19 reinfection to elevating women in academic research to highlighting racial and ethnic disparities in COVID-19 hospital mortality in Illinois.
-
New Course Preps Medical Students for the Next Disaster
Feinberg students are being trained in a two-week emergency preparedness course on how to manage natural disasters, mass shootings or pandemics.
-
Teaching AI to Read Fetal Ultrasound in Low- and Middle-Income Countries
Northwestern Medicine and Google are collaborating on a project to bring fetal ultrasound to developing countries by combining AI (artificial intelligence), low-cost hand-held ultrasound devices and a smartphone.
-
Pursuing Deeper Understanding about the Most Common Type of Heart Failure
Of the estimated five million patients in the U.S. diagnosed with heart failure annually, nearly half will have heart failure with preserved ejection fraction (HFpEF) and at the forefront of HFpEF research are Feinberg investigators.
-
Nanoparticle-Based COVID-19 Vaccine Could Target Future Infectious Diseases
A new publication outlines the structure-function relationships between the first spherical nucleic acid vaccine developed to protect against viral infections, including COVID-19.
-
Feinberg Hosts 2022 Research Retreat
Nearly 200 principal investigators gathered recently at the Fairmont Hotel for discussion and brainstorming to generate the research priorities that will help guide the Feinberg research enterprise for the next five years.
